| I hope this email finds you well. I wanted to bring to your attention some interesting information I came across regarding Inhibikase Therapeutics, Inc. (Nasdaq: IKT).
According to recent reports, shares of IKT have been trending near potential lines of resistance, including its 50-day moving average of $0.85 and its 100-day moving average of $1.76.
If IKT were to cross over these levels, it could lead to a significant increase in share price.
Furthermore, it's worth noting that if IKT were to reach its 2-year high of $9.16, it would cap off a massive 1,788% move. While this is not expected, it's worth keeping in mind given the potential.
As a small company with a market capitalization of around $20.29M and only around 19.85M shares in its float, IKT may be considered a low float stock.
This means that a large portion of its equity is held by controlling investors such as directors and employees, leaving only a small percentage of the stock available for public trading. As of 2/23/2023, insiders own over 21% of the shares.
Please note that nothing is certain in the stock market, and this information should not be considered as investment advice. It's important to conduct your own research and analysis before making any investment decisions.
Thank you for your time, and please let me know if you have any questions.
Best regards, Prime Tech Stocks Team |
没有评论:
发表评论